Yi-Chen Chang Selected Research

Yi-Chen Chang Research Topics

Disease

7	Neoplasms (Cancer) 11/2023 - 06/2002
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2018
5	Hyperalgesia 03/2006 - 02/2003
4	Osteoarthritis 01/2020 - 05/2005
3	Carcinogenesis 11/2023 - 01/2019
2	Liver Neoplasms (Liver Cancer) 10/2022 - 01/2018
2	Neuralgia (Stump Neuralgia) 03/2006 - 12/2003
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Fibrosis (Cirrhosis) 12/2020
1	Hepatitis 12/2020
1	Alzheimer Disease (Alzheimer's Disease) 06/2020
1	Postoperative Pain 01/2020
1	Infections 01/2019
1	Gastritis 01/2019
1	Experimental Liver Neoplasms 01/2018
1	Osteoporosis 01/2016
1	Empyema 11/2006
1	Staphylococcal Pneumonia 11/2006
1	Hemorrhage 04/2006
1	Multiple Organ Failure (MODS) 04/2006
1	Cancer Pain 06/2002
1	Pain (Aches) 06/2002

Drug/Important Bio-Agent (IBA)

5	Excitatory Amino AcidsIBA 05/2006 - 06/2002
3	hepatoma-derived growth factorIBA 11/2023 - 01/2019
3	Dialysis SolutionsIBA 05/2006 - 12/2003
3	Glutamic Acid (Glutamate)FDA Link 05/2006 - 06/2002
3	Aspartic Acid (Aspartate)FDA Link 05/2006 - 06/2002
3	Pertussis ToxinIBA 03/2006 - 02/2003
3	Morphine (MS Contin)FDA LinkGeneric 03/2006 - 06/2002
3	Opioid Analgesics (Opioids)IBA 03/2006 - 06/2002
2	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2022
2	Protein Kinase CIBA 03/2006 - 12/2003
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2005 - 07/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2005 - 07/2004
2	N-Methylaspartate (NMDA)IBA 12/2003 - 02/2003
2	chelerythrineIBA 12/2003 - 02/2003
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2003 - 02/2003
2	AcidsIBA 12/2003 - 02/2003
2	Analgesics (Analgesic Drugs)IBA 12/2003 - 06/2002
1	superoxide dismutase 2IBA 11/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2023
1	Superoxides (Superoxide)IBA 11/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	Troponin T (Troponin T1)IBA 05/2023
1	Chemotactic FactorsIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Antineoplastic Agents (Antineoplastics)IBA 10/2022
1	Dinoprostone (PGE2)FDA Link 07/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2021
1	Concanavalin AIBA 12/2020
1	Amyloid beta-PeptidesIBA 06/2020
1	EtoricoxibIBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	LigandsIBA 01/2018
1	Celecoxib (Celebrex)FDA Link 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	salmon calcitonin (Calcimar)FDA LinkGeneric 01/2016
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2016
1	Lugol's solution (Lugol's iodine)IBA 10/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2006
1	Hyaluronic Acid (Hyaluronan)IBA 05/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2005
1	p38 Mitogen-Activated Protein KinasesIBA 08/2005
1	Opioid Receptors (Opioid Receptor)IBA 12/2003
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2003
1	Amino Acids FDA Link 12/2003
1	protein kinase C gamma (PRKCG)IBA 12/2003
1	Protein Kinases (Protein Kinase)IBA 02/2003
1	Protein Isoforms (Isoforms)IBA 02/2003

Therapy/Procedure

2	Therapeutics 01/2018 - 11/2006
1	Drug Therapy (Chemotherapy) 01/2018
1	Thoracostomy 11/2006
1	Chest Tubes (Chest Tube) 11/2006
1	Thoracotomy 04/2006
1	Critical Care (Surgical Intensive Care) 04/2006
1	Spinal Injections 02/2003
1	Analgesia 06/2002